Kevin Ali leads the MSD International organization. The organization's geographic scope includes
Japan, China, Asia Pacific, Latin America, Europe, Middle East, Africa and Canada. MSD
International accounts for 96 percent of the world's population, and over half o f Merck & Co's
pharmaceutical and vaccines revenues.
In addition, Kevin has global responsibility for the company's Diversified Brands business, a
port folio of mature products that plays a critical role in serving the needs o f customers and
patients around the world.
Prior to assuming leadership of MSD International in 2017, Kevin led the Emerging Markets
region (Latin America, Eastern Europe, Middle East, Africa, and Asia Pacific) to several years of
strong, sustained, and leveraged growth. Over that period, he championed a strategic shift
towards the company's innovative products, the introduction of important commercial and
development partnerships and a number of transformational agreements with key customers.
Kevin is the Executive sponsor of the company's Enterprise Leadership Program (ELP), having
personally guided the design and deployment of its predecessor, the Emerging Markets Future
Prior to Emerging Markets, Kevin was Senior Vice President and General Manager o f the Bone,
Respiratory, Immunology and Dermatology (BRID) franchise; Senior Vice President and Managing
Director o f MSD in Germany; Managing Director of MSD in Turkey; Business Unit Director MSD
in Germany, Marketing Director MSD in Egypt, and Regional Product Manager for the Middle
East. Kevin began his MSD career in 1988, as a Hospital & Specialty Sales Representative in
Kevin holds an MBA from San ta Clara University in California and a Bachelor of Arts degree in
Development Studies from the University of California at Berkeley.